Spain, France, Germany, Italy and Poland have access to the largest numbers of drug trials.

Ten Guiding Principles of Good AI Practice in Drug Development is mentioned in the guidance

According to the report EMA recommended 104 medicines in 2025 and 38 had a new active substance. Also 16 medicines were approved for rare diseases including the first drug for Wiscott-ALdrich syndrome.

We wish a peacefull year full of health and happiness

The report on "Artificial intelligence in pharmacovigilance" addresses a rapidly emerging cross-disciplinary field that is at the intersection of pharmacovigilance, computer science, mathematics, regulation, law, medicine, human rights, psychology and social science.